Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey.Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion.The oral drug has not yet entered human trials, and Merck did not specify which diseases it plans to test the drug on first. Still, it boosts the pharmaceutical company's chances of winning a slice of the booming obesity drug market, which some analysts expect ...